Enovis (NYSE:ENOV – Free Report) had its price objective raised by Wells Fargo & Company from $73.00 to $79.00 in a report published on Friday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. A number of other equities research analysts have also recently weighed in on the stock. […]
Related Keywords
Montreal , Quebec , Canada , William Blair , Needham Company , Wells Fargo Company , Canaccord Genuity Group , Neuberger Berman Group , Enovis Corporation , Jpmorgan Chase Co , Free Report , Wells Fargo , Genuity Group , Stock Down , Get Free Report , Berman Group , Montreal Can , Enovis Daily , Genovis , Nyse Enov , Senov , Medical , Boost Price Target ,
comparemela.com © 2020. All Rights Reserved.